These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27236669)

  • 21. Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model.
    Furuta T; Miyaki S; Ishitobi H; Ogura T; Kato Y; Kamei N; Miyado K; Higashi Y; Ochi M
    Stem Cells Transl Med; 2016 Dec; 5(12):1620-1630. PubMed ID: 27460850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cell insights: prospects in cardiovascular therapy.
    Chou SH; Lin SZ; Kuo WW; Pai P; Lin JY; Lai CH; Kuo CH; Lin KH; Tsai FJ; Huang CY
    Cell Transplant; 2014; 23(4-5):513-29. PubMed ID: 24816448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism.
    Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.
    Tang YL; Zhao Q; Qin X; Shen L; Cheng L; Ge J; Phillips MI
    Ann Thorac Surg; 2005 Jul; 80(1):229-36; discussion 236-7. PubMed ID: 15975372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
    Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
    Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes.
    Sid-Otmane C; Perrault LP; Ly HQ
    J Transl Med; 2020 Sep; 18(1):336. PubMed ID: 32873307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair.
    Shao L; Zhang Y; Lan B; Wang J; Zhang Z; Zhang L; Xiao P; Meng Q; Geng YJ; Yu XY; Li Y
    Biomed Res Int; 2017; 2017():4150705. PubMed ID: 28203568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells overexpressing integrin-linked kinase attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions.
    Mao Q; Lin CX; Liang XL; Gao JS; Xu B
    Mol Med Rep; 2013 May; 7(5):1617-23. PubMed ID: 23450431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrine-Mediated Tissue Repair.
    Luo Q; Zhang B; Kuang D; Song G
    Curr Stem Cell Res Ther; 2016; 11(7):585-92. PubMed ID: 27306402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
    Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
    J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
    Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
    Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repair.
    Bartczak A; McGilvray I; Keating A
    Curr Opin Organ Transplant; 2017 Feb; 22(1):86-96. PubMed ID: 28005573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MODIFICATION OF MESENCHYMAL STEM CELLS AS A WAY TO IMPROVE THE EFFECTIVENESS OF CELL THERAPY OF ISCHEMIC MYOCARDIAL INJURY].
    Karpov AA; Drahova AV; Buslova DV; Ivkin DY; Moiseeva OM; Galagudza MM
    Ross Fiziol Zh Im I M Sechenova; 2015 Sep; 101(9):985-98. PubMed ID: 26672155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity.
    Ezquer FE; Ezquer ME; Vicencio JM; Calligaris SD
    Cell Adh Migr; 2017 Jan; 11(1):110-119. PubMed ID: 27294313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury.
    Khubutiya MS; Vagabov AV; Temnov AA; Sklifas AN
    Cytotherapy; 2014 May; 16(5):579-85. PubMed ID: 24113425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gelatin-based 3D conduits for transdifferentiation of mesenchymal stem cells into Schwann cell-like phenotypes.
    Uz M; Büyüköz M; Sharma AD; Sakaguchi DS; Altinkaya SA; Mallapragada SK
    Acta Biomater; 2017 Apr; 53():293-306. PubMed ID: 28213098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.
    Motavaf M; Pakravan K; Babashah S; Malekvandfard F; Masoumi M; Sadeghizadeh M
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):74-9. PubMed ID: 27453276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Keratinocyte Growth Factor in the Differentiation of Sweat Gland-Like Cells From Human Umbilical Cord-Derived Mesenchymal Stem Cells.
    Xu Y; Hong Y; Xu M; Ma K; Fu X; Zhang M; Wang G
    Stem Cells Transl Med; 2016 Jan; 5(1):106-16. PubMed ID: 26574554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.